Author(s): Hiba Sattar Jabbar and Safa Azhar Razzaq

Abstract: This metabolic-endocrine disorder is known as polycystic ovary syndrome (PCOS), Hyperandrogenism and anovulation are the most prominent symptoms. There is no known cause for PCOS, but insulin resistance has been associated with the condition, Reproductive and cardiovascular complications associated with glycemic changes. A precursor of phosphorinositides, myo-inositol (MYO) provides energy for cell function, A variety of functions are controlled by these proteins, including cell proliferation. Insulin resistance in PCOS patients is caused by altered inositol-phosphoglycan metabolism. Myo-inositol treatment is recommended based on available evidence together with folic acid, improves metabolic and reproductive outcomes for women with PCOS. PCOS patients can benefit from the use of MYO based on current knowledge associated with insulin resistance with or without obesity, improving the quality and maturation of oocytes and pregnancy outcomes in this important group of women.

Pages: 25-28 | Views: 347 | Downloads: 121

Download Full Article: Click Here